Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The burgeoning role of global health diplomacy to alleviate suffering of cancer patients in low- and middle-income countries.

Adomako M. et al, (2020), Int Health, 12, 231 - 233

The Oncology Data Network (ODN): Methodology, Challenges and Achievements.

Woolmore A. et al, (2020), Oncologist

Oncopolicy and global health diplomacy in times of rising populism.

Adomako M. et al, (2020), J Public Health Policy

Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019).

Ren L. et al, (2020), Eur J Surg Oncol

Deep learning for prediction of colorectal cancer outcome: a discovery and validation study.

Skrede O-J. et al, (2020), Lancet, 395, 350 - 360

Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer.

Ersvaer E. et al, (2019), Int J Cancer

A phase Ib/ II trial to assess the safety and efficacy of CXD101 in combination with the PD-1 inhibitor nivolumab in patients with metastatic, previously-treated, microsatellite-stable (MSS) colorectal carcinoma (short title CAROSELL)

Saunders MP. et al, (2019), ANNALS OF ONCOLOGY, 30

Correction: Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage.

Glaire MA. et al, (2019), Br J Cancer, 121

ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: Results of a prospective single-center clinical utility study-PRECISE study.

Lee LYW. et al, (2019), Cancer Med, 8, 6305 - 6314

The Oncology Data Network (ODN): A Collaborative European Data-Sharing Platform to Inform Cancer Care.

Kerr D. et al, (2019), Oncologist

Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage

GLAIRE M. et al, (2019), British Journal of Cancer

Hand-foot syndrome is a biomarker of improved survival following treatment with capecitabine.

Jandu H. et al, (2019), Ann Oncol, 30 Suppl 4, iv117 - iv118

ToxNav germline genetic testing and PROMinet digital mobile application toxicity monitoring: results of a prospective single centre clinical utility study (PRECISE STUDY).

Lee L. et al, (2019), Ann Oncol, 30 Suppl 4

Challenges and solutions in patient treatment strategies for stage II colon cancer.

Fotheringham S. et al, (2019), Gastroenterol Rep (Oxf), 7, 151 - 161

Association analyses identify 31 new risk loci for colorectal cancer susceptibility.

Law PJ. et al, (2019), Nat Commun, 10

Confirmation that somatic mutations of beta-2 microglobulin correlate with a lack of recurrence in a subset of stage II mismatch repair deficient colorectal cancers from the QUASAR trial.

Barrow P. et al, (2019), Histopathology

Oxford Textbook of Cancer Biology

Pezzella F. et al, (2019)

Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features.

Jiang W. et al, (2019), Int J Cancer, 144, 2161 - 2168

An FBXW7-ZEB2 axis links EMT and tumour microenvironment to promote colorectal cancer stem cells and chemoresistance.

Li N. et al, (2019), Oncogenesis, 8

A phase 1 study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer.

Eyre TA. et al, (2019), Cancer, 125, 99 - 108

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?